Elicio Therapeutics, Inc. (ELTX) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$37.71M | +16.2% |
| 2024 | -$44.99M | -25.9% |
| 2023 | -$35.74M | -50.6% |
| 2022 | -$23.73M | +39.6% |
| 2021 | -$39.31M | +28.9% |
| 2020 | -$55.27M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$37.71M | +16.2% |
| 2024 | -$44.99M | -25.9% |
| 2023 | -$35.74M | -50.6% |
| 2022 | -$23.73M | +39.6% |
| 2021 | -$39.31M | +28.9% |
| 2020 | -$55.27M | — |